SESSION SUMMARIES

Medical and Medical Logistics Challenges for Expeditionary Forces on the Modern Battlefield. Coming soon...

Senior Executive Leadership Panel: Medical Acquisition Priorities and Opportunities Across DoW and VA. Coming soon...

Business Opportunities with the Department of War, Defense Health Agency & Defense Logistics Agency. Panel presenters will identify requirements Department of War, Defense Health Agency and Defense Logistics Agency for medical products and services, devices, pharmaceuticals, training, IT and staffing needs.  They will also outline the processes they utilize to acquire these products and services, including prime vendors, GSA schedules, Governmentwide Acquisition Contracts (GWACs) and commercial contracts.  Business forecasts will also be shared. Prospective primes, subcontractors and suppliers, including small businesses, should attend this session.

Business Opportunities in Operational & Medical Logistics with Military Service Medical Commands. Military service medical commands and the broader military health enterprise provide business opportunities for companies specializing in operational logistics, medical supply chains, healthcare technology, and readiness support.  This session’s experts will discuss: medical supply chain & distribution, healthcare IT & medical logistics systems, medical equipment lifecycle management, operational & expeditionary medicine support and business forecasts.  This session is for companies that have demonstrative capabilities in: medical readiness, supply chain resilience, healthcare IT modernization and expeditionary medical support.

Business Opportunities with the Department of Veterans Affairs. Panel presenters will identify requirements of Department of Veterans Affairs (VA) medical centers and clinics in the region for medical products and services, including research and development, supplies, equipment, devices, pharmaceuticals, training, IT and staff augmentation.  They will also outline the processes they utilize to acquire these products and services, including use of prime vendors, GSA schedules, Governmentwide Acquisition Contracts (GWACs) and commercial contracts.  Businesses and researchers with the capacity to support VA medical centers and clinics, vendors or other business with medical products or services should participate in this session.

AI Enabled Healthcare: “Doc in a Box." Coming soon...

From Requirement to Reality: Industry on the Front Lines.  Military and federal medical agencies face an increasingly complex operational environment where speed, readiness, resilience, and innovation are no longer optional-they are mission critical. From battlefield medicine and force health protection to veteran care, biodefense preparedness, AI-enabled diagnostics, advanced manufacturing, logistics, and human performance optimization, the gap between identified capability requirements and deployable real-world solutions continues to narrow.

This panel brings together leaders from defense industry, military medicine, federal acquisition, and operational communities to examine how emerging requirements become fielded capabilities. Panelists will discuss the realities of responding to urgent operational needs, navigating federal procurement pathways, aligning innovation with mission priorities, and overcoming the common barriers that slow transition from prototype to deployment. The discussion will also explore how small businesses, research institutions, manufacturers, and nontraditional defense contractors can better engage with the Department of Defense, the Defense Health Agency, the Department of Veterans Affairs, and prime integrators to accelerate outcomes for warfighters and veterans.

Attendees will gain insight into:

  • Current military medical and biodefense capability gaps
  • How operational requirements are generated and validated
  • What industry gets right—and wrong—when responding to federal needs
  • The role of rapid acquisition, OTA agreements, SBIR/STTR programs, and public-private partnerships
  • Lessons learned from recent operational medical challenges
  • Future opportunities in military healthcare, biomedical innovation, and national preparedness

The session is designed to create candid dialogue between requirement owners, acquisition leaders, frontline operators, and solution providers working at the intersection of healthcare innovation and national defense.

Innovation Opportunities in Chemical, Biological, Radiological & Nuclear Defense. Coming soon...

Medical Innovation Opportunities with Consortia and Federal Agencies.  The session will discuss the opportunities available for research and development, prototyping, and production through Other Transaction Authorities (OTAs) of the Federal Government. OTAs represent a growing sector of government acquisition with many potential advantages for non-traditional entities over FAR-based contracts. OTAs are used by Capability Program Executive for Chemical, Biological, Radiological and Nuclear Defense (CPE CBRND), the Defense Health Agency (DHA), and other federal agencies.

Department of Veterans Affairs One-On-One Meetings. The Department of Veterans Affairs will host one-on-one meetings with industry. This forum provides a unique opportunity for dialogue with key decision makers from multiple Veterans Affairs offices.  Participants should bring capabilities statements and prepare a concise “elevator pitch” to communicate a compelling business case for the Veterans Affairs to procure their goods and/or services.

 

 

 

103 days
left to
Medical, Biomedical & Biodefense: Support to the Warfighter and Veteran Symposium